Package 67877-719-60

{"route": ["ORAL"], "spl_id": "33247fe5-9b47-4513-93fe-fc65e4c1b63f", "openfda": {"nui": ["N0000175605", "N0000175076", "N0000182141", "N0000182137", "N0000175625", "N0000175624", "N0000175550"], "upc": ["0367877721316", "0367877720319", "0367877719313", "0367877718316"], "unii": ["9HW64Q8G6G"], "rxcui": ["977427", "977434", "977438", "2056895"], "spl_set_id": ["2693c497-a70b-4d00-b6db-602c872e5bed"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["Kinase Inhibitor [EPC]", "mTOR Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Protein Kinase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "mTOR Inhibitors [MoA]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (67877-719-31)  / 10 TABLET in 1 BLISTER PACK (67877-719-33)", "package_ndc": "67877-719-31", "marketing_start_date": "20211127"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (67877-719-60)", "package_ndc": "67877-719-60", "marketing_start_date": "20240301"}], "brand_name": "Everolimus", "product_id": "67877-719_33247fe5-9b47-4513-93fe-fc65e4c1b63f", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "67877-719", "generic_name": "Everolimus", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Everolimus", "active_ingredients": [{"name": "EVEROLIMUS", "strength": ".5 mg/1"}], "application_number": "ANDA214138", "marketing_category": "ANDA", "marketing_start_date": "20211127", "listing_expiration_date": "20261231"}